Avadel Pharmaceuticals Plc
(NASDAQ) AVDL
Avadel Pharmaceuticals Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$248.52M
Net Income (TTM)
$278.00K
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AVDL News
AVDL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avadel Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
188
CEO
Gregory J. Divis, Jr., PhD
Website
www.avadel.comHeadquarters
Dublin, 2, IE
AVDL Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
2%
Net Income Margin
-0%
Return on Equity
-0%
Return on Capital
3%
Return on Assets
-0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$153.84M
Operating Income
$42.40M
EBITDA
$35.57M
Operating Cash Flow
$46.91M
Capital Expenditure
$0.00
Free Cash Flow
$46.91M
Cash & ST Invst.
$73.78M
Total Debt
$1.70M
Avadel Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$77.47M
+54.9%
Gross Profit
$80.47M
+83.4%
Gross Margin
1.04%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
188
N/A
Net Income
$20.00K
+100.8%
EBITDA
$3.58M
+171.9%
Quarterly Fundamentals
Net Cash
$54.20M
-15.1%
Accounts Receivable
$42.44M
+14.4%
Inventory
$23.91M
+48.5%
Long Term Debt
$36.64M
+2913.0%
Short Term Debt
$740.00K
+2.1%
Return on Assets
-0.14%
N/A
Return on Invested Capital
3.30%
N/A
Free Cash Flow
$23.25M
+437.4%
Operating Cash Flow
$23.26M
+437.6%